Pentagalloylglucose Downregulates Cofilin1 and Inhibits HSV-1 Infection.
Ying Pei,Yang-Fei Xiang,Jia-Nan Chen,Chun-Hua Lu,Jing Hao,Qian Du,Chi-choi Lai,Chang Qu,Shen Li,Huai-Qiang Ju,Zhe Ren,Qiu-Ying Liu,Sheng Xiong,Chui-Wen Qian,Fan-Li Zeng,Pei-Zhuo Zhang,Chong-Ren Yang,Ying-Jun Zhang,Jun Xu,Kaio Kitazato,Yi-Fei Wang
DOI: https://doi.org/10.1016/j.antiviral.2010.11.012
IF: 7.6
2010-01-01
Antiviral Research
Abstract:To investigate the anti-herpesvirus mechanism of pentagalloylglucose (PGG), we compared the proteomic changes between herpes simplex virus type 1 (HSV-1) infected MRC-5 cells with or without PGG-treatment, and between non-infected MRC-5 cells with or without PGG-treatment by 2-DE and MS-based analysis. Differentially expressed cellular proteins were mainly involved with actin cytoskeleton regulation. Significantly, PGG can down-regulate cofilin1, a key regulator of actin cytoskeleton dynamics. PGG can inhibit HSV-1-induced rearrangements of actin cytoskeleton which is important for infectivity. Furthermore, cofilin1 knockdown by siRNA also inhibited the HSV-1-induced actin-skeleton rearrangements. Both PGG-treatment and cofilin1 knockdown can reduce HSV-1 DNA, mRNA, protein synthesis and virus yields. Altogether, the results suggested that down-regulating cofilin1 plays a role in PGG inhibiting HSV-1 infection. PGG may be a promising anti-herpesvirus agent for drug development.